Adjuvent & Co. SPRL
Adjuvent & Co. reported total assets of 24,723 € at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Jun 2026).
The score of Adjuvent & Co. shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -26 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Adjuvent & Co.'s annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Jun 2026
- Year ended 31 Dec 2024filed on 20 Jun 2025
- Year ended 31 Dec 2023filed on 05 Apr 2024
- Year ended 31 Dec 2022filed on 02 Jun 2023
- Year ended 31 Dec 2021filed on 25 Apr 2022
Adjuvent & Co.'s financial analysis
- Solvency-123.0%sector median: 50.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Adjuvent & Co.
Adjuvent & Co.'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0864.349.083
- VAT number
- BE0864349083
- Peppol
- Registered · 0208:0864349083 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 26 Mar 2004
- Registered office
- 1000 Brussels
- Latest accounts
- 2025 · filed on 25 Jun 2026
- Activity
- Public relations and communication activities (NACE 73300)
Adjuvent & Co. (SPRL) has been based in Brussels since 2004, active in: public relations and communication activities. For 2025, it reports a net profit of 14,124 € and equity of −30,413 €; its revenue is not published. Its solvency stands at -123.0%, below the median of its sector (50.0%).
Companies similar to Adjuvent & Co.
Companies in the same business, of comparable size and area, outside its group.
- Ximcom Public relations and communication activities As · balance sheet 28,351 €
- Synapse Company Public relations and communication activities Watermael-Boitsfort · balance sheet 30,879 €
- B.S.S Management Public relations and communication activities Enghien · balance sheet 35,058 €
- Highseat Public relations and communication activities Stekene · balance sheet 39,055 €
- Gephyr Public relations and communication activities Awans · balance sheet 31,330 €
- BD Consultancy Services Public relations and communication activities Huldenberg · balance sheet 6,967 €
- ICatch Public relations and communication activities Bekkevoort · balance sheet 35,608 €
- Maamtys Public relations and communication activities Scherpenheuvel-Zichem · balance sheet 45,442 €
Frequently asked questions about Adjuvent & Co.
What is the revenue of Adjuvent & Co.?
Adjuvent & Co. files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Adjuvent & Co.?
In Belgium, the VAT number is the company number prefixed with BE: BE0864349083 for Adjuvent & Co., if the company is VAT-registered. Its company number (CBE) is 0864.349.083.
Where is the registered office of Adjuvent & Co.?
According to the CBE register, the registered office of Adjuvent & Co. is in 1000 Brussels.
What is the equity of Adjuvent & Co.?
At the close of the 2025 financial year, the equity of Adjuvent & Co. amounts to -30,413 €, a solvency of -123.0% of total assets.
Who manages Adjuvent & Co.?
The register lists 2 active mandates at Adjuvent & Co.. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Adjuvent & Co.
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →